Disclosure of interest: Dr Rohid Zamani: Nothing to disclose, Dr Daniel McWilliams: nothing to disclose, Dr Sameer Limaye: Nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.04 - STROKE COMPLICATIONS P2566 - ESOC25-2302 CEREBRAL SALT-WASTING SYNDROME IN PATIENTS WITH ACUTE ISCHEMIC STROKE: A NARRATIVE LITERATURE REVIEW Nikolaos Faraklas Perdikouris 1 , Athanasios Vasilopoulos 2 , Athanasios Mitsias 1 , Panayiotis Mitsias 1,3,4 1 School of Medicine, University of Crete, Heraklion, Greece, 2 University Hospital of Lyon, Lyon, France, 3 University Hospital of Heraklion, Heraklion, Greece, 4 Department of Neurology, Henry Ford Hospital, Detroit, United States Background and Aims: Hyponatremia is a common complication of acute stroke and may be the result of inappropriate ADH Secretion (SIADH) or cerebral salt-wasting syndrome (CSWS)
From a molecular point of view, DMF has been shown to inhibit virus entry by inducing anti-protease protein SPLI expression and inhibiting transmembrane serine protease TRMPSS2, a cell surface receptor, required for SARS-CoV-2 entry to target host cells [162]
Like Ac-SDKP-OH, Ac-LKKTETQ-OH is a fragment of TB-4
Overall, I respect his commitment to scientific accuracy and his standard of excellence with his approach
